These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8050177)

  • 1. Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.
    Vitale G; Mocciaro C; Malta R; Gambino G; Spinelli A; Giordano C; Stassi G; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1994 Aug; 97(2):280-3. PubMed ID: 8050177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
    Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
    Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
    Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
    Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
    Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
    Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble CD4 and CD8 levels in Kawasaki disease.
    Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
    Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
    Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
    Sawada S; Hashimoto H; Iijima S; Tokano Y; Takei M; Shida M; Obara T
    J Clin Lab Anal; 1993; 7(3):141-6. PubMed ID: 8509943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.
    North ME; Spickett GP; Webster AD; Farrant J
    Clin Exp Immunol; 1991 Nov; 86(2):252-5. PubMed ID: 1934593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
    Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
    Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
    Balázs C; Bokk A; Farid NR
    Thyroid; 1994; 4(1):27-30. PubMed ID: 8054859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis.
    Schriefer A; Barral A; Carvalho EM; Barral-Netto M
    Clin Exp Immunol; 1995 Dec; 102(3):535-40. PubMed ID: 8536369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
    Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
    Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI).
    Reddy MM; McKinley GF; Grieco MH
    J Clin Lab Anal; 1991; 5(6):396-8. PubMed ID: 1774603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
    Weiss C; Wulf G; Ho AD; Hunstein W
    Immunol Lett; 1991 Sep; 30(1):113-8. PubMed ID: 1683649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: comparison of immunological markers in patients with acute and remission phase.
    De Pità O; Ruffelli M; Cadoni S; Frezzolini A; Biava GF; Simom R; Bottari V; De Sanctis G
    J Dermatol Sci; 1996 Nov; 13(2):118-24. PubMed ID: 8953411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD4 and CD8 molecules in patients with systemic sclerosis.
    Tokano Y; Kaneko H; Obara T; Hashimoto H; Okumura K; Hirose S
    Clin Rheumatol; 1993 Dec; 12(4):490-3. PubMed ID: 8124911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
    Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
    Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrajejunal elemental diet perfusion on local secretion of soluble CD4 and CD8.
    Desreumaux P; Levy A; Vaerman JP; Capron M; Cortot A; Colombel JF
    Clin Exp Immunol; 1996 May; 104(2):293-6. PubMed ID: 8625523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble CD4, CD8 and IL-2R levels in adult acute myeloid leukemia in remission.
    Iizuka Y; Aiso M; Ohshima T; Sawada S; Horie T
    Med Oncol Tumor Pharmacother; 1992; 9(2):57-64. PubMed ID: 1341717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.
    Nockher WA; Bergmann L; Scherberich JE
    Clin Exp Immunol; 1994 Dec; 98(3):369-74. PubMed ID: 7527738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.